These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4046859)

  • 1. Poly(lactic/glycolic acid) biodegradable drug-polymer matrix systems.
    Kitchell JP; Wise DL
    Methods Enzymol; 1985; 112():436-48. PubMed ID: 4046859
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and characterization of poly(lactic acid-co-glycolic acid) complex microspheres as drug carriers.
    Wang F; Liu X; Yuan J; Yang S; Li Y; Gao Q
    J Biomater Appl; 2016 Oct; 31(4):544-552. PubMed ID: 27368752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The preparation and characterization of poly(D,L-lactic acid) for use as a biodegradable drug carrier.
    Rak J; Ford JL; Rostron C; Walters V
    Pharm Acta Helv; 1985; 60(5-6):162-9. PubMed ID: 4023019
    [No Abstract]   [Full Text] [Related]  

  • 4. Bupivacaine-loaded biodegradable poly(lactic-co-glycolic) acid microspheres I. Optimization of the drug incorporation into the polymer matrix and modelling of drug release.
    Zhang H; Lu Y; Zhang G; Gao S; Sun D; Zhong Y
    Int J Pharm; 2008 Mar; 351(1-2):244-9. PubMed ID: 18024022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New biodegradable oligoesters for pharmaceutical application.
    Wada R; Hyon SH; Ikada Y
    J Biomater Sci Polym Ed; 1996; 7(8):715-25. PubMed ID: 8639480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoscale surface characterization and miscibility study of a spray-dried injectable polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone.
    Meeus J; Chen X; Scurr DJ; Ciarnelli V; Amssoms K; Roberts CJ; Davies MC; van Den Mooter G
    J Pharm Sci; 2012 Sep; 101(9):3473-85. PubMed ID: 22447580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants.
    Cossé A; König C; Lamprecht A; Wagner KG
    AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of biodegradable poly(propylene fumarate)/poly(lactic-co-glycolic acid) blend microspheres. II. Controlled drug release and microsphere degradation.
    Kempen DH; Lu L; Zhu X; Kim C; Jabbari E; Dhert WJ; Currier BL; Yaszemski MJ
    J Biomed Mater Res A; 2004 Aug; 70(2):293-302. PubMed ID: 15227674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro release of theophylline from poly(lactic acid) sustained-release pellets prepared by direct compression.
    Kader A; Jalil R
    Drug Dev Ind Pharm; 1998 Jun; 24(6):527-34. PubMed ID: 9876618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ortho ester) biodegradable polymer systems.
    Heller J; Himmelstein KJ
    Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. pH-responsive release of proteins from biocompatible and biodegradable reverse polymer micelles.
    Koyamatsu Y; Hirano T; Kakizawa Y; Okano F; Takarada T; Maeda M
    J Control Release; 2014 Jan; 173():89-95. PubMed ID: 24200745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of water-soluble additives on drug release kinetics from biodegradable poly(lactic-co-glycolic acid) matrix].
    Song LP; Yang J; Wang H; Sun HF; Tang LN; Wu L; Chang J; Song CX
    Yao Xue Xue Bao; 2005 Jun; 40(6):557-62. PubMed ID: 16144325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of P(L)LA-PEG-P(L)LA as processing aid for biodegradable particles from gas saturated solutions (PGSS) process.
    Perinelli DR; Bonacucina G; Cespi M; Naylor A; Whitaker M; Palmieri GF; Giorgioni G; Casettari L
    Int J Pharm; 2014 Jul; 468(1-2):250-7. PubMed ID: 24746690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biodegradable poly (lactic acid) microspheres for drug delivery systems.
    Hyon SH
    Yonsei Med J; 2000 Dec; 41(6):720-34. PubMed ID: 11204823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.
    Fredenberg S; Wahlgren M; Reslow M; Axelsson A
    Int J Pharm; 2011 Aug; 415(1-2):34-52. PubMed ID: 21640806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug delivery systems.
    Davis SS; Illum L
    Practitioner; 1983 Oct; 227(1384):1537-43. PubMed ID: 6634624
    [No Abstract]   [Full Text] [Related]  

  • 17. Structure formation and characterization of injectable drug loaded biodegradable devices: in situ implants versus in situ microparticles.
    Kranz H; Bodmeier R
    Eur J Pharm Sci; 2008 Jul; 34(2-3):164-72. PubMed ID: 18501569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescein isothiocyanate labelled bovine serum albumin (FITC-BSA) as a model protein drug: opportunities and drawbacks.
    Wischke C; Borchert HH
    Pharmazie; 2006 Sep; 61(9):770-4. PubMed ID: 17020153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intravitreal drug delivery by microspheres of biodegradable polymers].
    Moritera T; Ogura Y; Honda Y; Wada R; Hyon SH; Ikada Y
    Nippon Ganka Gakkai Zasshi; 1990 May; 94(5):508-13. PubMed ID: 2220493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation and sustained release of a model drug, indomethacin, using CO(2)-based microencapsulation.
    Liu H; Finn N; Yates MZ
    Langmuir; 2005 Jan; 21(1):379-85. PubMed ID: 15620328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.